Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer

NCT05617040 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
22
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was discontinued following completion of the Phase 1 portion. This discontinuation was not based on safety concerns.

Conditions

Interventions

Sponsor

Barinthus Biotherapeutics